CONFERENCE DAY ONE

8:00 am Check-In & Coffee

Synopsis

Light Breakfast Served

8:55 am Chair’s Opening Remarks

9:00 am Reach, Relevance, Impact: How to Build Enduring Measurement Infrastructures

Synopsis

  • Tracing the journey of measuring patient engagement and experience, with a focus on key trends
  • Identifying which trends are expected to persist, which have plateaued, and which are reversing to refine best practices
  • Envisioning the future of patient engagement measurement to create a strategic roadmap and ensure accurate data collection for evolving needs

Creating Standardized Metrics & Reporting Patient Engagement Across the Whole Product Lifecycle

9:30 am Identifying & Quantifying Underserved Communities & Unmet Needs – A Spotlight on the Spot Her Campaign

  • Teresa Cronin Vice President - Corporate Communications & Patient Advocacy, Eisai

Synopsis

  • Exploring how incorporating direct patient insights helped the Spot Her campaign connects with broader audiences and amplify its impact
  • Learning how data-driven insights from patient engagement outcomes informed the development of more targeted strategies, ensuring sustained efforts and meaningful connections with underserved communities
  • Discovering the benefits of collaborating with professional and patient organizations to highlight mutual efforts, amplify disease awareness, and enhance program visibility for greater impact

10:00 am Quantifying the Value of Proactive vs. Reactive Patient Input in the Drug Development Lifecycle

  • Josee Pelletier Senior Director, Research & Drug Development, Global Patient Advocacy Corporate Affairs, BMS

Synopsis

  • Identifying critical times in drug development life cycle where advocacy and patient engagement provide valuable insights
  • Determining the optimal timing to ask proactive questions to maximize engagement effectiveness
  • Navigating organizational structures to advocate for proactive patient engagement and making a compelling case to teams focused on other metrics

10:30 am Speed Networking Session

Synopsis

Join our speed networking session tailored for Patient Engagement professionals, like yourselves, to connect with fellow industry peers to facilitate rapid yet meaningful exchanges of insights and expertise. Elevate your networking experience during this session designed for impactful connections within the space.

11:00 am Morning Break & Networking

Synopsis

Light Breakfast Served

11:30 am Measuring the Benefits of Incorporating Patient Insights in Early Trial Planning

Synopsis

  • Exploring methods for quantitatively measuring the advantages of engagement patients in early trial planning, including within the trial design process and identifying key endpoints
  • Ensuring comprehensive representation of your entire community
  • Identifying effective strategies to utilise patient measurements to improve trial design and therefore outcome

12:00 pm Benchmarking Success: Key Metrics to Elevate Patient Recruitment & Engagement in Clinical Trials

  • Adrienne Gaggi Director of Innovative Patient Recruitment, AstraZeneca

Synopsis

  • Emphasizing the importance of tracking patient engagement as well as recruitment efforts
  • Examining the decision-making process for selecting the right metrics
  • Analyzing the outcomes of tailored metrics on recruitment and retention success

12:30 pm Audience Discussion: Measuring the Impact of Patient Experience Insights in Marketing & Commercialization Activities

Synopsis

  • Addressing the challenges and opportunities in measuring the impact of patient engagement during the marketing and commercialization phases of the product lifecycle
  • Identifying the most effective channels for gathering patient feedback and exploring innovative ways to engage with them meaningfully
  • Evaluating strategies to empower patient stakeholders with the information they need to make well-informed decisions that optimize patient outcomes

1:00 pm Lunch & Networking

Synopsis

Hot Lunch Served

2:00 pm Overcoming Constraints in Quantifying ROI When You Can’t Drive Demand

Synopsis

  • How can we take data and information and compliantly use it within the market space, given the tight constraints around driving demand and influencing prescribing behaviour
  • Examining where we can push the envelope on leveraging patients as the ‘North star’ in a compliant manner, what can be said in the public domain, and what are the risks
  • Understanding what patient engagement metrics can and can’t be shared with patients to increase awareness around products in a complaint manner

2:30 pm Finding the Right Mechanisms to Obtains Patient Feedback without Burdening Them

  • Amy Fisher Senior Director, Patient Advocacy, Spark Therapeutics

Synopsis

  • Examining practical example of collection patient satisfaction in a meaningful way without burdening them
  • Exploring new software and tools that can be utilized to collect data from patients
  • Analysing the results from implementing this new technology

3:00 pm Afternoon Break & Networking

Synopsis

Light Refreshments Served

3:30 pm Practical Session: Measuring & Demonstrating the Value of Patient Engagement Across the Medicines Life Cycle

Synopsis

In this practical session, we will be revisiting Novartis’ Patient Engagement Impact Measurement Framework and its pivotal role in driving patient-centric drug development and integration into healthcare.

Key Takeaways:

  • Examine the next steps in applying the Patient Engagement Impact Measurement Framework to enhance measurable outcomes
  • Identify the critical tools, resources, and collaborations needed to operationalize the framework effectively
  • Address key challenges and critical success factors in implementing the framework to deliver actionable insights and sustainable value

Join this session to find out if your fellow attendees have successfully incorporated this framework into their everyday working lives, the opportunities to use this framework to streamline your patient engagement activities, and future developments for the tool.

5:00 pm Closing Remarks

5:05 pm End of Day One